Table 2 Multivariable predictors of mortality among persons diagnosed with AIDS in San Francisco, 1996–2006 (N = 6163)*

   No

Referent

   Yes

1.20

1.03, 1.41

Gender

   Male

Referent

   Female

0.80

0.65, 0.98

   Transgender

1.14

0.87, 1.51

Age at diagnosis (years)

   <40

Referent

   ≥ 40

1.67

1.50, 1.86

Race/ethnicity

   White

Referent

   African American

0.96

0.83, 1.10

   Latino

0.83

0.70, 0.98

   Asian/Pacific Islander/Native American/Other

0.77

0.59, 0.99

Risk group

   Men who have sex with men

Referent

   Injection drug user

1.88

1.59, 2.23

   Men who have sex with men and inject drugs

1.52

1.32, 1.76

   Heterosexual/Other

1.48

1.14, 1.93

Insurance status

   Private

Referent

   Public

2.12

1.82, 2.48

   None

1.60

1.39, 1.84

Initial AIDS diagnosis

   CD4 count < 200 cells/mm³

Referent

   Opportunistic illness

1.41

1.24, 1.60

CD4 count at diagnosis ^†

0.90

0.88, 0.92

Ever received highly active antiretroviral therapy

   No

Referent

   Yes

0.82

0.72, 0.93

Ever received prophylaxis against Pneumocystis jirovecii pneumonia

   No

Referent

   Yes

0.89

0.80, 1.00

Ever received prophylaxis against Mycobacterium avium complex

   No

Referent

   Yes

0.94

0.83, 1.07